GRCE
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Grace Therapeutics receives FDA Type A meeting minutesJul 28, 2026
- Grace Therapeutics pivotal Phase 3 STRIVE-ON safety trial presented at 2025 Neurocritical Care annual meetingSep 22, 2025
- Grace Therapeutics granted sixth U.S. patent covering I.V. dosing regimen for GTx-104Sep 18, 2025
- Grace Therapeutics announces FDA acceptance for review of new drug application for GTx-104Aug 27, 2025